Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan in Non-Erosive Gastroesophageal Reflux Disease
NCT01474369Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan in Non-erosive Gastroesophageal Reflux Disease (NERD), sponsored by Takeda. Started Dec 2011; status: completed.
02
Drugs
vonoprazan
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on NCT01474369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474369.